tiprankstipranks
Marinomed Biotech AG (DE:93Z)
FRANKFURT:93Z
Germany Market
93Z
Marinomed Biotech AG
RESEARCH TOOLSreports

Marinomed Biotech AG (93Z) Financial Statements

1 Followers

Marinomed Biotech AG Financial Overview

Marinomed Biotech AG's market cap is currently €21.50M. The company's EPS TTM is €-9.2; its P/E ratio is 1.12; Marinomed Biotech AG is scheduled to report earnings on May 26, 2026, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Mar 23Dec 21Dec 20Dec 19
Income Statement
Total Revenue€ 9.18M€ 11.28M€ 11.63M€ 8.12M€ 6.14M
Gross Profit€ 1.14M€ 2.14M€ 1.42M€ -641.70K€ -512.30K
Operating Income€ -5.13M€ -5.75M€ -4.14M€ -6.96M€ -6.21M
EBITDA€ -3.62M€ -3.21M€ -3.58M€ -4.86M€ -6.22M
Net Income€ -6.79M€ -6.40M€ -5.89M€ -6.01M€ -7.22M
Balance Sheet
Cash & Short-Term Investments€ 2.59M€ 8.18M€ 5.80M€ 9.21M€ 12.02M
Total Assets€ 14.61M€ 22.29M€ 21.34M€ 23.50M€ 19.50M
Total Debt€ 21.80M€ 22.63M€ 15.80M€ 12.81M€ 4.64M
Net Debt€ 19.21M€ 14.45M€ 10.00M€ 3.61M€ -7.38M
Total Liabilities€ 24.75M€ 26.44M€ 21.15M€ 18.14M€ 8.64M
Stockholders' Equity€ -10.14M€ -4.16M€ 191.40K€ 5.36M€ 10.87M
Cash Flow
Free Cash Flow€ -4.66M€ -5.43M€ -5.79M€ -10.85M€ -9.98M
Operating Cash Flow€ -4.53M€ -5.20M€ -4.87M€ -6.88M€ -7.64M
Investing Cash Flow€ -128.50K€ -207.50K€ -918.80K€ -3.96M€ -2.38M
Financing Cash Flow€ -929.70K€ 7.78M€ 2.38M€ 8.01M€ 20.32M
Currency in EUR

Marinomed Biotech AG Earnings and Revenue History

Income Statement >

Marinomed Biotech AG Debt to Assets

Balance Sheet >

Marinomed Biotech AG Cash Flow

Cash Flow >

Marinomed Biotech AG Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
Earnings >